Associations of nickel exposure with diabetes: evidence from observational studies.
Weihang XiaXianwei GuoPeng XieLinya FengBirong WuJuan GaoShaodi MaHaixia LiuChenyu SunGuangbo QuYehuan SunPublished in: Environmental science and pollution research international (2023)
The results of environmental epidemiological studies regarding the relationship between human exposure to nickel and the risk of diabetes remain controversial. Therefore, we performed a meta-analysis to investigate the relationship between nickel exposure and diabetes. PubMed, Web of Science, and Embase electronic databases were thoroughly searched from their inception to May 2023 to obtain relevant studies. The random-effects model was employed to determine pooled odds ratios (ORs) and 95% confidence intervals (CIs). Stratified and sensitivity analyses were also performed. Cochran Q test and I 2 statistic were employed to assess heterogeneity between studies. Begg's and Egger's tests were employed to evaluate publication bias. The indicated studies were evaluated using the ROBINS-E risk of bias tool. The dose-response relationship between nickel in urine and diabetes risk was estimated by restricted cubic spline. A total of 12 studies with 30,018 participants were included in this study. In this meta-analysis, comparing the highest vs. lowest levels of nickel exposure, the pooled ORs for diabetes were 1.42 (95% confidence interval 1.14-1.78) for urine and 1.03 (0.57-1.86) for blood, respectively. A linear relationship between urinary nickel and diabetes risk was discovered in the dose-response analysis (P nonlinearity = 0.6198). Each 1 µg/L increase of urinary nickel, the risk of diabetes increased by 7% (OR = 1.07, 95% CI 1.04-1.10). The risk of diabetes was positively correlated with urine nickel exposure, whereas the risk was not significantly correlated with blood nickel. In the future, more high-quality prospective studies are needed to validate this conclusion.
Keyphrases
- type diabetes
- cardiovascular disease
- glycemic control
- case control
- reduced graphene oxide
- systematic review
- oxide nanoparticles
- metal organic framework
- carbon nanotubes
- randomized controlled trial
- endothelial cells
- clinical trial
- machine learning
- metabolic syndrome
- gold nanoparticles
- adipose tissue
- single cell
- risk assessment
- open label
- study protocol
- current status